Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Affimed N.V. (NASDAQ: AFMD).

Full DD Report for AFMD

You must become a subscriber to view this report.


Recent News from (NASDAQ: AFMD)

Affimed Therapeutics' (AFMD) CEO, Adi Hoess on Q1 2018 Results - Earnings Call Transcript
Affimed Therapeutics (AFMD) Q1 2018 Earnings Conference Call May 15, 2018 9:00 am ET Executives Adi Hoess - Chief Executive Officer Florian Fischer - Chief Financial Officer Leila Alland - Chief Medical Officer Anca Alexandru - Head of Communications Analysts Do Kim - BMO...
Source: SeekingAlpha
Date: May, 15 2018 13:53
Affimed Therapeutics 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Affimed Therapeutics in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: May, 15 2018 10:47
Week 19 Breakout Forecast: Short-Term Picks To Give You An Edge
Breakout Forecast Selections for Week 19: Market conditions continue with high volatility. The positive momentum gauge spent another full week in yellow (medium) moving from a value of 52 last week up to a value of 61 this week. The all time low for the positive momentum selection gauge...
Source: SeekingAlpha
Date: May, 06 2018 01:42
Blog Exposure - Preclinical Data Presented by Bayer at AACR Highlights Compugen's BAY 1905254 Efficacy in Cancer Immunotherapy
Stock Monitor: Affimed Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 19, 2018 / Active-Investors.com has just released a free research report on Compugen Ltd (NASDAQ: CGEN ). If you want access to this report all you need to do is sign up now by clicking the following link ...
Source: ACCESSWIRE IA
Date: April, 19 2018 07:40
Week 16 Breakout Forecast: Short-Term Picks To Give You An Edge
Breakout Forecast Selections for Week 16: Market conditions continue with extreme volatility. The positive momentum gauge has finally moved into the yellow from a value of 14 to a value of 40. Volatility in the market remains at high levels and we have not been above the midpoint value of 60...
Source: SeekingAlpha
Date: April, 15 2018 14:29
Affimed Therapeutics' (AFMD) CEO Adi Hoess on Q4 2017 Results - Earnings Call Transcript
Affimed Therapeutics (AFMD) Q4 2017 Earnings Conference Call March 20, 2018 08:30 ET Executives Anca Alexandru - Head-Communications Adi Hoess - CEO Florian Fischer - CFO Analysts Presentation Operator Good day, welcome to the Affimed Fourth Quarter and Year End 201...
Source: SeekingAlpha
Date: March, 20 2018 14:58
Affimed reports FY results
Affimed (NASDAQ: AFMD ): FY EPS of -€0.69 More news on: Affimed Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: March, 20 2018 07:35
Affimed (AFMD) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow
The following slide deck was published by Affimed Therapeutics in conjunction with this Read more ...
Source: SeekingAlpha
Date: March, 15 2018 13:21
Midday Gainers / Losers (2/13/2018)
Gainers: CATB +56% . AQMS +30% . GNC +30% . TYHT +26% . OPNT +23% . OSN +22% . CHGG +18% . AXON +15% . VECO +15% . UAA +15% . More news on: Catabasis Pharmaceuticals, Aqua Metals, GNC Holdings, Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: February, 13 2018 12:50
Premarket Losers as of 9:05 am (2/13/2018)
DARE   -33%  on  announcing public offering of common stock. More news on: Dare Bioscience, Inc., Helios and Matheson Analytics, Inc., Pacific Biosciences of California, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: February, 13 2018 09:17

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-171.501.551.601.50130,965
2018-08-161.501.551.551.475290,705
2018-08-151.451.501.501.45200,592
2018-08-141.551.451.601.40152,658
2018-08-131.601.55191.64221.5593,769

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1740,01252,29276.5165Short
2018-08-1633,428236,15414.1552Cover
2018-08-1563,206185,85834.0077Cover
2018-08-1427,13666,45240.8355Short
2018-08-1311,23845,09824.9191Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AFMD.


About Affimed N.V. (NASDAQ: AFMD)

Logo for Affimed N.V. (NASDAQ: AFMD)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: AFMD)

      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: May, 15 2018
      Amendment to a SC 13D filing
      Filing Type: SC 13D/AFiling Source: edgar
      Filing Date: April, 04 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: March, 20 2018
      Annual and transition report of foreign private issuers under sections 13 or 15(d)
      Filing Type: 20-FFiling Source: edgar
      Filing Date: March, 20 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: March, 08 2018
      Amendment to a SC 13D filing
      Filing Type: SC 13D/AFiling Source: edgar
      Filing Date: February, 22 2018
      Amendment to a SC 13D filing
      Filing Type: SC 13D/AFiling Source: edgar
      Filing Date: February, 21 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: February, 16 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: February, 15 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: February, 14 2018

       

       


      Daily Technical Chart for (NASDAQ: AFMD)

      Daily Technical Chart for (NASDAQ: AFMD)


      Stay tuned for daily updates and more on (NASDAQ: AFMD)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: AFMD)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AFMD is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of AFMD and does not buy, sell, or trade any shares of AFMD. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/